Initiating mepolizumab within 3 months of EGPA diagnosis is associated with a higher remission rate, earlier glucocorticoid withdrawal, and less damage accrual.
Social and economic factors may drive COVID-19 hospitalization risk more than HIV status among reproductive-age women in the Southern US.
The predictive variables assessed were age at EGPA diagnosis, baseline eosinophil count, history of chronic sinusitis prior to diagnosis, and glucocorticoid-treated asthma at diagnosis.
FAYETTEVILLE, GA, UNITED STATES, January 26, 2026 /EINPresswire.com/ -- Postoperative recurrence remains the main ...
NRG-BR007: A phase III trial evaluating de-escalation of breast radiation (DEBRA) following breast-conserving surgery of stage 1, HR+, HER2-, RS ≤18 breast cancer. This is an ASCO Meeting Abstract ...
Dupilumab remained effective in most patients with atopic dermatitis (AD) up to 5 years, although nearly a quarter of patients in the cohort study discontinued treatment because of adverse events (AEs ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results